In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis

被引:2
|
作者
Donadieu, Maxime [1 ]
Lee, Nathanael J. [1 ,2 ]
Gaitan, Maria, I [1 ]
Ha, Seung-Kwon [1 ,3 ]
Luciano, Nicholas J. [1 ]
Roy, Snehashis [4 ]
Ineichen, Benjamin [1 ,5 ]
Leibovitch, Emily C. [6 ]
Yen, Cecil C. [7 ]
Pham, Dzung L. [8 ]
Silva, Afonso C. [3 ,7 ]
Johnson, Mac [9 ]
Jacobson, Steve [6 ]
Sati, Pascal [1 ,10 ]
Reich, Daniel S. [1 ]
机构
[1] Natl Inst Neurol Disorders & Stroke, Translat Neuroradiol Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA
[2] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA USA
[3] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA
[4] Natl Inst Mental Hlth, Sect Neural Funct, NIH, Bethesda, MD USA
[5] Univ Zurich, Univ Hosp Zurich, Clin Neurosci Ctr, Dept Neuroradiol, Zurich, Switzerland
[6] Natl Inst Neurol Disorders & Stroke, Viral Immunol Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD USA
[7] Natl Inst Neurol Disorders & Stroke, Cerebral Microcirculat Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD USA
[8] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD USA
[9] Vertex Pharmaceut Inc, Boston, MA USA
[10] Cedars Sinai, Dept Neurol, Neuroimaging Program, Los Angeles, CA 90048 USA
来源
ELIFE | 2023年 / 12卷
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
marmoset; EAE; MRI; remyelination; primate; histopathology; Other; DEMYELINATION; LESIONS; ASSOCIATION; MARMOSET;
D O I
10.7554/eLife.73786
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Remyelination is crucial to recover from inflammatory demyelination in multiple sclerosis (MS). Investigating remyelination in vivo using magnetic resonance imaging (MRI) is difficult in MS, where collecting serial short-interval scans is challenging. Using experimental autoimmune encephalomyelitis (EAE) in common marmosets, a model of MS that recapitulates focal cerebral inflammatory demyelinating lesions, we investigated whether MRI is sensitive to, and can characterize, remyelination. In six animals followed with multisequence 7 T MRI, 31 focal lesions, predicted to be demyelinated or remyelinated based on signal intensity on proton density-weighted images, were subsequently assessed with histopathology. Remyelination occurred in four of six marmosets and 45% of lesions. Radiological-pathological comparison showed that MRI had high statistical sensitivity (100%) and specificity (90%) for detecting remyelination. This study demonstrates the prevalence of spontaneous remyelination in marmoset EAE and the ability of in vivo MRI to detect it, with implications for preclinical testing of pro-remyelinating agents.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] In vivo MRI measurement of demyelination and remyelination in the cuprizone mouse model
    Merkler, D
    Boretius, S
    Stadelmann, G
    Ernsting, T
    Awn, N
    Michaelis, T
    Frahm, J
    Brück, W
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S229 - S229
  • [32] REMYELINATION IN MULTIPLE-SCLEROSIS
    PRINEAS, JW
    CONNELL, F
    ANNALS OF NEUROLOGY, 1979, 5 (01) : 22 - 31
  • [33] Remyelination Therapy for Multiple Sclerosis
    Michael B. Keough
    V. Wee Yong
    Neurotherapeutics, 2013, 10 : 44 - 54
  • [34] Promoting remyelination in multiple sclerosis
    Nick Cunniffe
    Alasdair Coles
    Journal of Neurology, 2021, 268 : 30 - 44
  • [35] REMYELINATION IN MULTIPLE-SCLEROSIS
    PRINEAS, JW
    CONNELL, F
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1978, 37 (05): : 675 - 675
  • [36] Remyelination Therapy in Multiple Sclerosis
    Harlow, Danielle E.
    Honce, Justin M.
    Miravalle, Augusto A.
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [37] Remyelination Therapy for Multiple Sclerosis
    Keough, Michael B.
    Yong, V. Wee
    NEUROTHERAPEUTICS, 2013, 10 (01) : 44 - 54
  • [38] Regulation of remyelination in multiple sclerosis
    Hanafy, Khalid A.
    Sloane, Jacob A.
    FEBS LETTERS, 2011, 585 (23) : 3821 - 3828
  • [39] Promoting remyelination in multiple sclerosis
    Cunniffe, Nick
    Coles, Alasdair
    JOURNAL OF NEUROLOGY, 2021, 268 (01) : 30 - 44
  • [40] MRI-guided immunotherapy development for multiple sclerosis in a primate
    't Hart, BA
    Smith, P
    Amor, S
    Strijkers, GJ
    Blezer, ELA
    DRUG DISCOVERY TODAY, 2006, 11 (1-2) : 58 - 66